New Research: Folic Acid Supplementation May Prevent Diabetes-Related Peripheral Neuropathy

Researchers at Florida State University have found in a mouse model that increasing dietary folic acid intake can prevent diabetes-related peripheral neuropathy. The study highlights the importance of special nutritional requirements for people with chronic conditions like diabetes and obesity, with clinical trials planned.

New Research: Folic Acid Supplementation May Prevent Diabetes-Related Peripheral Neuropathy

A New Link Between Folic Acid and Nerve Health

Researchers at Florida State University (FSU) recently published a notable study in the Proceedings of the National Academy of Sciences (PNAS). Using a mouse model, they demonstrated that significantly increasing dietary folic acid intake can effectively prevent peripheral neuropathy. This is a common complication associated with diabetes and other health issues, characterized by numbness, tingling, burning sensations, and weakness in the hands and feet.

Why is Folic Acid So Important?

Folic acid is the synthetic form of vitamin B9 and is essential for DNA synthesis. This process occurs throughout life as cells are constantly renewed and is crucial for nerve protection. Low folate levels are linked not only to the risk of birth defects but also to the severity and incidence of peripheral neuropathy.

Professor Patrick Stover, the principal investigator of the study, pointed out that government Recommended Dietary Allowances (RDAs) are typically set for healthy populations to prevent nutrient deficiencies. However, many people with chronic conditions like diabetes and obesity may have different, higher nutritional requirements, termed "special nutritional requirements."

Research Implications and Future Directions

This study, conducted in a mouse model, showed that a high-dose folic acid regimen prevented peripheral neuropathy in susceptible mice. The research also revealed that peripheral neuropathy and neural tube defects (NTDs) share a common genetic etiology.

The research team plans to conduct clinical trials in Tallahassee. Professor Stover stated, "If we see the same results in humans, which we believe we will, based on the literature that’s out there and what we’ve shown in this paper, that will change the standard of care."

Significance for Patients

Peripheral neuropathy affects the lives of millions:

  • The Centers for Disease Control and Prevention (CDC) estimates there were 40.1 million people with diabetes in the United States in 2023.
  • The Cleveland Clinic reports that about 50% of people with diabetes experience some degree of peripheral neuropathy.
  • The MD Anderson Cancer Center notes that 30-40% of cancer patients each year experience peripheral neuropathy, either from the cancer itself or from chemotherapy drugs.

Current treatments for neuropathy primarily focus on alleviating symptoms, managing underlying causes, and relieving pain. If nutritional interventions like folic acid supplementation are proven effective for prevention, it could significantly improve patients' quality of life.